Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 17, 2026
Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Key Takeaways

  • Shares of AIRS fell 11.37% to $3.04 in Monday trading, down $0.39 from Friday’s close of $3.43.
  • The decline extends post-earnings turbulence following the company’s August 10 second-quarter report.
  • Q2 revenue of $42.9 million missed consensus and fell 3% year over year; the full-year adjusted EBITDA outlook was cut to $12–$14 million.
  • No fresh company-specific announcement was apparent during Monday’s slide, pointing to technical and sentiment-driven selling.
  • Traders are watching the $3.00 area and upcoming Q3 case-volume and margin trends.

Opening Summary

AirSculpt Technologies, Inc. (AIRS) is a provider of minimally invasive body contouring procedures in the United States and Canada. In Monday afternoon trading, shares dropped 11.37% to $3.04, compared with Friday’s close of $3.43. The decline extended a period of elevated volatility that began when the company reported second-quarter results on August 10, and the market’s immediate focus remained on the weaker profitability outlook rather than on any new corporate announcement.

Q2 Results and Lowered Profit Outlook

The primary overhang on AIRS remains the second-quarter report released before the market open on August 10. Revenue came in at $42.9 million, down 3% from $44.0 million a year earlier and below the consensus estimate of roughly $44.2 million. Net loss widened to $1.1 million from $0.6 million in the prior-year period, while adjusted EBITDA declined to $4.9 million from $5.8 million.

Management reaffirmed full-year revenue guidance but said results are expected to track toward the lower end of the $151 million-to-$157 million range. More importantly for investor sentiment, the company reduced its full-year adjusted EBITDA guidance to $12 million-to-$14 million. That downward revision to profitability expectations has kept selling pressure on the stock even after the initial post-earnings reaction.

Technical Selling and Post-Earnings Volatility

The stock’s recent path illustrates how volatile AIRS has become. The shares closed at $5.01 on August 7, then collapsed to $2.75 on August 10 after the earnings release. A partial recovery followed over the next four sessions, lifting the stock back to $3.43 by August 14. Monday’s slide to $3.04 unwound most of that rebound in a single session.

With a beta near 2.4 and a relatively small float, AIRS is prone to outsized intraday moves. The absence of a fresh company-specific catalyst during Monday’s decline suggests that the move was driven by continued digestion of the lowered earnings outlook, profit-taking after last week’s bounce, and momentum-driven selling once the shares surrendered key short-term support.

Market Context and Trading Activity

Turnover in AIRS has been elevated relative to early-August levels since the earnings report. Daily volume surged to roughly 2.5 million shares on August 10 and remained well above the early-August baseline in subsequent sessions, reflecting intense two-way trading as investors repositioned.

The selling on Monday appeared largely company-specific rather than tied to a broad market catalyst. The stock’s slide below the $3.30 level and toward $3.00 placed it back near the lower end of its recent post-earnings range, a technical breakdown that likely contributed to additional selling pressure during the afternoon.

What Comes Next for AIRS

Investors will be watching whether AIRS can stabilize above the $3.00 level or whether the post-earnings range continues to compress. The next scheduled quarterly report is expected in November, and management commentary on same-center case volumes, revenue per case, and adjusted EBITDA margins will be central to the investment debate.

Additional focus areas include the rollout of newer procedures such as skin tightening and skin removal, the planned AlloClae pilot, demand trends among GLP-1 patients, and progress on debt refinancing. Consumer spending on elective cosmetic procedures remains a key macroeconomic risk, and the company’s ability to convert higher marketing investment into sustained case growth will likely determine whether the recent volatility gives way to a more durable trend.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to explore automated approaches tailored to different market environments. Investors seeking a data-driven way to monitor opportunities across active tickers may find the section a useful starting point.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AIRS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AIRS in downward trend: price dove below 50-day moving average on August 10, 2026

AIRS moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend. In of 29 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for AIRS crossed bearishly below the 50-day moving average on August 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AIRS entered a downward trend on September 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AIRS's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where AIRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 04, 2026. You may want to consider a long position or call options on AIRS as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AIRS just turned positive on September 03, 2026. Looking at past instances where AIRS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AIRS advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

AIRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AIRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.922) is normal, around the industry mean (238.659). P/E Ratio (196.563) is within average values for comparable stocks, (132.252). AIRS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.615). AIRS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (1.224) is also within normal values, averaging (2.670).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.74B. The market cap for tickers in the group ranges from 48.5K to 87.68B. HCA holds the highest valuation in this group at 87.68B. The lowest valued company is BYZN at 48.5K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 32%. WW experienced the highest price growth at 11%, while NIVF experienced the biggest fall at -70%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was -46% and the average quarterly volume growth was 62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 47
Price Growth Rating: 51
SMR Rating: 65
Profit Risk Rating: 87
Seasonality Score: -41 (-100 ... +100)
View a ticker or compare two or three
AIRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 786 709-9690
Employees
453
Web
https://www.airsculpt.com
Interact to see
Advertisement
Netflix dropped out of a months‑long bidding war for Warner Bros Discovery after Paramount/Skydance raised their offer, and Netflix refused to match it, saying the new price was “no longer financially appealing.” The stock jumped roughly 10%+ on the news as investors read this as fiscal discipline—management chose not to overpay, which protects the balance sheet and future returns instead of chasing scale at any price.
SE shares plunged approximately 23% at Tuesday's open, marking one of the steepest single-session selloffs in recent company history. The primary catalyst was a severe Q4 2025 earnings miss: adjusted EPS of $0.63 fell well short of the analyst consensus of $0.80, a miss of roughly 21%.
Shares of Southern Copper Corporation (SCCO) are down 10.32% in Tuesday's session, trading at $196.27 versus the prior close of $218.85 — a single-day loss of $22.58 per share. The primary catalyst is a Bank of America downgrade issued on March 2, cutting SCCO from Neutral to Underperform, which triggered accelerating sell pressure into Tuesday's open.
MDB shares plummeted approximately 26.44% on March 3, 2026, closing around $238.24, down from a prior close of approximately $322.55. The primary catalyst was weaker-than-expected fiscal Q1 2027 guidance, with non-GAAP EPS projected at $1.15–$1.19 versus analyst expectations of roughly $1.46.
Shares of Battalion Oil Corporation (BATL) are surging approximately +130% in Tuesday's session, with the stock hitting a fresh 52-week high as of intraday trading on March 3, 2026. The dominant catalyst is a sharp escalation of U.S.-Israel-Iran military tensions, with Tehran restricting access to the Strait of Hormuz — triggering a spike in crude oil futures and a broad-based energy sector rally.
Shares of CRDO dropped 18.55% on March 3, 2026, falling from a prior close of $114.22 to approximately $93.03. The primary catalyst was a "sell the news" reaction to fiscal Q3 2026 earnings — despite beating consensus estimates on both revenue and EPS, the market sold off on forward margin compression guidance.
PSIX shares plummeted approximately 25.37% on March 3, 2026, closing near $64.00 versus the prior session's close of $85.75. The primary catalyst was the company's Q4 and full-year 2025 earnings report, which revealed Q4 net income fell 31% year-over-year to $16.1 million despite a 33% revenue increase.
Life360 Inc Common (LIF) stunned many traders today as the stock slid more than 20% despite reporting what, on the surface, looked like very strong results: revenue up roughly 32% year over year to about $489.5 million and the company’s first-ever full‑year profitability.
StoneCo Ltd. (STNE) shares dropped more than 15% today after the market reacted negatively to the company’s latest Q4 2025 and full‑year results and its updated outlook. While StoneCo delivered year‑over‑year revenue and earnings growth and even topped EPS expectations, investors focused on weaker‑than‑hoped revenue numbers, rising credit risk metrics, and a more cautious medium‑term guidance profile, which together triggered a sharp rerating of the stock.
Alamo Group reported Q4 2025 EPS of about 1.70 dollars, well below analyst expectations that were in the low‑2 dollar range, producing a sizable negative earnings surprise. Quarterly revenue came in around 373.7 million dollars, down roughly 3% year over year and about 7–8% below consensus estimates near 405 million dollars, signaling softer demand than the market anticipated.
Hycroft Mining Holding Corp (HYMC) shares slid more than 12% today as traders digested the company’s newly filed 2025 annual report, a major corporate update, and an extended development timeline that shifts the story further away from near‑term production and cash flow.
PicS (PICS) shares dropped more than 12% today as investors reacted to mounting concerns about valuation, elevated volatility, and uncertainty ahead of the company’s next earnings report later in March.
Shares of MOBX surged approximately +532.77% in the March 3, 2026 trading session, closing at $1.12 versus a prior close of $0.18. The primary catalyst was a major production purchase order from the U.S. Navy for components used in the Tomahawk cruise missile program.
DAKT shares are declining approximately -10% in Wednesday's session, trading near $23.91, compared to the prior close of approximately $26.57. The primary catalyst is the pre-market release of fiscal Q3 2026 earnings, in which diluted EPS of $0.06 fell significantly short of the consensus estimate of approximately $0.13–$0.15.
Shares of HRZN plunged approximately 23% in Wednesday's trading session — one of the steepest single-day declines in the company's recent history. Primary catalyst: Q4 2025 earnings released after the close on March 3 revealed net investment income (NII) per share of just $0.18, badly missing the consensus estimate of $0.26 and marking a steep sequential decline.
Palantir (PLTR) is outperforming a struggling market, rallying strongly over the past few sessions while approaching a critical resistance level near $143. With geopolitical tensions rising and defense analytics demand growing, the stock sits at a pivotal technical moment that could determine its next major move.
Investors holding record levels of protective puts means downside is heavily hedged, which often dampens crash risk but supports higher implied volatility (VIX) in the short run. The fact that the S&P 500 and Nasdaq are rising while hedging is surging suggests a “wall of worry” market: people are bullish enough to stay in, but nervous enough to pay up for insurance.
During the week of 9–15 February 2026, major U.S. equity indices finished lower overall, while Tickeron’s trending AI trading bots produced positive returns, particularly in defense and energy—two areas now directly affected by the newly opened war in Iran. With macro risk rising and volatility picking up, this divergence matters: it shows how sector‑focused, rules‑based AI strategies can still find upside when broad index exposure is negative.
Investors are furiously hedging against a potential credit market crash, just as geopolitical risk explodes with a new war in Iran. Put option open interest on major U.S. credit ETFs like HYG, JNK, LQD, and BKLN has surged to a record ~11.5 million contracts, doubling over the last 12 months and already exceeding the 2022 bear‑market peak of 10 million.
The current gap between single‑stock implied volatility and index volatility is back near October 2008 extremes, signaling that investors expect idiosyncratic risk (stock‑specific jumps) to dominate.